Background: Few studies have investigated the association between Apolipoprotein E (APOE) polymorphisms and chronic kidney disease (CKD) in the general population, and their results are inconsistent.
INTRODUCTION
Apolipoprotein E (APOE ) is a key component in lipoprotein complexes and has a central role in cholesterol and triglyceride metabolism. [1] [2] [3] The APOE gene has three common alleles (E2, E3, and E4) that arise from two single nucleotide polymorphisms in exon 4, producing six possible genotypes (E2E2, E2E3, E2E4, E3E3, E3E4, and E4E4). 4) APOE isoforms differ in their receptor binding ability, as the APOE E2 allele has a cholesterol-lowering effect and the APOE E4 allele has a cholesterol-raising effect compared with the APOE E3 allele. 5) Thus, APOE polymorphisms are expected to play a major role in the pathogenesis and progression of a variety of renal diseases. 6) However, there are discrepancies in the literature regarding the role of APOE polymorphisms in the genetic predisposition to kidney disease. Two studies provide evidence that the APOE E2 allele confers a genetic risk, 7, 8) whereas others indicate that the APOE E4 allele is a risk factor for the progression of renal failure. 9, 10) Yet others demonstrate no association between APOE polymorphisms and kidney disease. 11, 12) The aim of the present study was to evaluate the association between APOE polymorphisms, estimated glomerular filtration rate (eGFR), and chronic kidney disease (CKD) in a Korean general population aged ≥ 50 years.
METHODS

Study Population and Data Collection
The Dong-gu Study is an ongoing prospective study to investigate the prevalence, incidence, and risk factors for chronic disease in an urban population. National resident registration records were used to identify potential participants. In total, 34,040 eligible subjects of ≥50 years of age who resided in the 
Apolipoprotein E Genotyping
Genomic DNA was extracted from peripheral blood using either an AccuPrep Genomic DNA Extraction Kit (Bioneer, Seoul, Korea) or a QIAamp DNA Mini Kit (Qiagen Inc., Chatsworth, CA, USA) according to the manufacturer's protocol.
APOE genotypes were determined using the polymerase chain reaction as described by Hixson and Vernier, 13) with a slight modification. The APOE genotyping method used in this study has been reported previously.
14)
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Estimation of Glomerular Filtration Rate and Chronic Kidney Disease
Kidney function was assessed by calculating the eGFR using Table 1 shows the general characteristics of the subjects and their relationships with APOE alleles. Participants with the APOE E2 allele had significantly lower total and low density had significantly lower log-triglyceride levels (P < 0.001) than those with the APOE E2 or E4 allele. Participants with the APOE E4 allele had significantly lower HDL cholesterol levels (P < 0.001) than those with the APOE E2 or E3 allele. ; P = 0.873). ).
RESULTS
General Characteristics of the Subjects according to Apolipoprotein E Allele
Comparison of Mean Estimated Glomerular Filtration Rate according to Apolipoprotein E Allele
Odds Ratios for Chronic Kidney Disease according to Apolipoprotein E Allele
Model I: adjusted age and sex. Model II: further adjusted for body mass index, smoking, systolic blood pressure, diabetes, hypertension, total cholesterol, high density lipoprotein cholesterol, log-transformed triglycerides, and log-transformed albumin to creatinine ratio.
E2: E2E2 and E2E3; E3:E3E3; E4: E3E4 and E4E4.
*Statistical analysis by logistic regression.
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levels, and those with the APOE E3 allele had significantly lower log-triglyceride levels. Additionally, eGFR estimates were not significantly different among subjects with different APOE alleles, and the APOE polymorphisms were not independent risk factors for CKD in this population.
Participants with the APOE E2 allele showed significantly lower total and LDL cholesterol levels than those with the APOE E3 or E4 allele. This finding is consistent with previous studies. 14, 17, 18) The inability of APOE E2 isoforms to effectively bind LDL and APOE receptors decreases the amount of In contrast to the lack of a correlation between APOE alleles and LDL cholesterol levels, the associations between APOE alleles and HDL cholesterol and triglyceride levels are not entirely clear. In the present study, participants with the APOE E4 allele had the lowest HDL cholesterol levels in accordance with previous reports. 14, 17) However, other researchers have reported no association between APOE alleles and HDL cholesterol levels. 19, 20) Many investigators have demonstrated that participants with the APOE E3 allele have the lowest triglyceride levels, 14, 18, 20) similar to our results. However, another study reported that female subjects with the APOE E2 allele have the lowest triglyceride levels. 21) Gene-environment interactions may have contributed to the discrepancies between studies. HDL cholesterol levels are modulated by smoking, alcohol consumption, physical activity, and diet. 22, 23) In another Korean study, 14) the associations between the APOE alleles and HDL cholesterol levels were affected by age, and the associations between APOE alleles and triglyceride levels were affected by smoking status.
In the present study, eGFR did not differ significantly among the APOE alleles, and APOE polymorphisms were not independent risk factors for CKD. Several studies have investigated the relationship between APOE alleles and renal function. However, most of these studies were conducted on patients with diabetes [7] [8] [9] [10] [11] [12] alleles. In the present study, APOE E2E4 was excluded due to the potential opposing biological effects of the APOE E2 and APOE E4 alleles. Only APOE E2E3 and APOE E3E3 alleles were compared in the RENASTUR study with a Spanish Caucasian population. 20) Moreover, the definition of CKD 24, 25) and the methods for estimating GFR 19, 26) were different in each study.
We do not know why APOE polymorphism affected lipid profiles but not eGFR or CKD in our Korean study participants.
One potential explanation is that gene-environment interactions may contribute to this discrepancy. 14) Another explanation is that a low allele frequency within the study population resulted in an underpowered analysis that did not detect significant associations.
In the ARIC study, 24) the APOE E2 allele frequency was 14.2%
and that of the APOE E4 allele was 28.6%. In the Cardiovascular Health Study, 25) the frequencies of the APOE E2 and E4 alleles were 13.7% and 23.0%, respectively. In the present study, the APOE E2 allele frequency was 11.4% and the APOE E4 allele frequency 16.8%. Finally, APOE polymorphisms may not be associated with or minimally affect the kidney function of Korean study participants.
The present study had some limitations. First, the study was cross-sectional. Second, no direct eGFR measurements were obtained. The gold standard for measuring GFR is inulin clearance, but this was not feasible in a large epidemiologic study.
